NEW YORK (GenomeWeb) – Fulgent Genetics reported on Monday that its second quarter revenues rose 17 percent as it integrated its newly reorganized sales force.

For the three months ended June 30, Fulgent's revenues climbed to $4.6 million from $4.0 million the year before.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.